CoChat

G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests

Open access
Domingo, Gonzalo J, Satyagraha, Ari Winasti, Anvikar, Anup, Baird, Kevin, Bancone, Germana, Bansil, Pooja, Carter, Nick, Cheng, Qin, Culpepper, Janice, Eziefula, Chi, Fukuda, Mark, Green, Justin, Hwang, Jimee, Lacerda, Marcus, McGray, Sarah, Menard, Didier, Nosten, Francois, Nuchprayoon, Issarang, Oo, Nwe Nwe, Bualombai, Pongwit, Pumpradit, Wadchara, Qian, Kun, Recht, Judith, Roca, Arantxa, Satimai, Wichai, Sovannaroth, Siv, Vestergaard, Lasse S, Von Seidlein, Lorenz · 2013 · Malaria Journal
Cited by 160

The DOI matches its Crossref record.

Abstract

Malaria elimination will be possible only with serious attempts to address asymptomatic infection and chronic infection by both Plasmodium falciparum and Plasmodium vivax. Currently available drugs that can completely clear a human of P. vivax (known as "radical cure"), and that can reduce transmission of malaria parasites, are those in the 8-aminoquinoline drug family, such as primaquine. Unfortunately, people with glucose-6-phosphate dehydrogenase (G6PD) deficiency risk having severe adverse reactions if exposed to these drugs at certain doses. G6PD deficiency is the most common human enzyme defect, affecting approximately 400 million people worldwide.Scaling up radical cure regimens will require testing for G6PD deficiency, at two levels: 1) the individual level to ensure safe case management, and 2) the population level to understand the risk in the local population to guide Plasmodium vivax treatment policy. Several technical and operational knowledge gaps must be addressed to expand access to G6PD deficiency testing and to ensure that a patient's G6PD status is known before deciding to administer an 8-aminoquinoline-based drug.In this report from a stakeholder meeting held in Thailand on October 4 and 5, 2012, G6PD testing in support of radical cure is discussed in detail. The focus is on challenges to the development and evaluation of G6PD diagnostic tests, and on challenges related to the operational aspects of implementing G6PD testing in support of radical cure. The report also describes recommendations for evaluation of diagnostic tests for G6PD deficiency in support of radical cure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1475-2875-12-391

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 160

Metadata

Authors
Domingo, G. J., Satyagraha, A. W., Anvikar, A., Baird, K., Bancone, G., Bansil, P., Carter, N., Cheng, Q., Culpepper, J., Eziefula, C., Fukuda, M., Green, J., Hwang, J., Lacerda, M., McGray, S., Menard, D., Nosten, F., Nuchprayoon, I., Oo, N. N., Bualombai, P., Pumpradit, W., Qian, K., Recht, J., Roca, A., Satimai, W., Sovannaroth, S., Vestergaard, L. S., & Von Seidlein, L.
Venue
Malaria Journal
Published
2013-11-04
Volume
12
Issue
1
Pages
391-391
ISSN
1475-2875 (ISSN-L)
OpenAlex
W2165752279
Cited by
160
References
0
FWCI
11.66
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. https://app.cochat.ai/papers/10.1186/1475-2875-12-391
The paper
Domingo, G. J., Satyagraha, A. W., Anvikar, A., Baird, K., Bancone, G., Bansil, P., Carter, N., Cheng, Q., Culpepper, J., Eziefula, C., Fukuda, M., Green, J., Hwang, J., Lacerda, M., McGray, S., Menard, D., Nosten, F., Nuchprayoon, I., Oo, N. N., . . . Von Seidlein, L. (2013). G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malaria Journal. https://doi.org/10.1186/1475-2875-12-391

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.